Recombinant IL2RA (Daclizumab Biosimilar) antibody

Catalog No. ABIN5580847

Product Details anti-IL2RA (Daclizumab Biosimilar) Antibody

Target: IL2RA (Daclizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This IL2RA (Daclizumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), Blocking Peptide (BP)

Purpose: Recombinant human monoclonal antibody raised against human IL2RA.

Specificity: This antibody binds to p55 chain of IL2RA on human T cells.

Cross-Reactivity: Human

Immunogen: Original antibody is raised against cultured T-cells derived from a patient with mycosis fungoides.

Isotype: IgG1 kappa

Application Details

Application Notes: Blocking
Flow Cytometry (1 μg/mL)
The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: In PBS, pH 7.2 (0.02 % Proclin 300).

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C for up to 3 months. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Target Details for IL2RA (Daclizumab Biosimilar)

Target: IL2RA (Daclizumab Biosimilar)

Abstract: IL2RA (Daclizumab Biosimilar) Products

Synonyms: CD25 antibody, IDDM10 antibody, IL2R antibody, TCGFR antibody, interleukin 2 receptor subunit alpha antibody, IL2RA antibody

Target Type: Biosimilar

Background: Full Gene Name: interleukin 2 receptor, alpha
Synonyms: CD25,IDDM10,IL2R,TCGFR

Gene ID: 3559

UniProt: P01589